Effectiveness of Seasonal Trivalent Influenza Vaccine for Preventing Influenza Virus Illness Among Pregnant Women: A Population-Based Case-Control Study During the 2010–2011 and 2011–2012 Influenza Seasons
Author(s) -
Mark G. Thompson,
DeKun Li,
Pat Shifflett,
Leslie Z. Sokolow,
Jeannette Ferber,
Samantha K. Kurosky,
Sam Bozeman,
Sue Reynolds,
Roxana Odouli,
Michelle L. Henninger,
Tia L. Kauffman,
Lyndsay A. Avalos,
Sarah Ball,
Jennifer L. Williams,
Stephanie A. Irving,
David K. Shay,
Allison L. Naleway,
Susan Y. Chu,
Janet D. Cragan,
Anne F McIntyre,
Julie Villanueva,
Alicia M. Fry,
J. Bresee,
Jerome I. Tokars,
Jane F. Seward
Publication year - 2013
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cit750
Subject(s) - medicine , vaccination , influenza vaccine , confidence interval , influenza like illness , case control study , virus , influenza a virus , population , human mortality from h5n1 , immunology , virology , environmental health , infectious disease (medical specialty) , disease , covid-19
Although vaccination with trivalent inactivated influenza vaccine (TIV) is recommended for all pregnant women, no vaccine effectiveness (VE) studies of TIV in pregnant women have assessed laboratory-confirmed influenza outcomes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom